Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

HKT-500-US12 In Adult Patients With OA Knee Pain

ClinicalTrials.gov ID: NCT00647231

Public ClinicalTrials.gov record NCT00647231. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Study identification

NCT ID
NCT00647231
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Jun 4, 2015

2008

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
Hisamitsu Investigator Site Birmingham Alabama 35209 —
Hisamitsu Investigator Site Phoenix Arizona 85013 —
Hisamitsu Investigator Site Little Rock Arkansas 72205 —
Hisamitsu Investigator Site Little Rock Arkansas 72211 —
Hisamitsu Investigator Site Burbank California 91505 —
Hisamitsu Investigator Site Escondido California 92025 —
Hisamitsu Investigator Site Northridge California 91325 —
Hisamitsu Investigator Site Colorado Springs Colorado 80909 —
Hisamitsu Investigator Site DeLand Florida 32720 —
Hisamitsu Investigator Site Hallandale Florida 33009 —
Hisamitsu Investigator Site Ocala Florida 34474 —
Hisamitsu Investigator Site Ormond Beach Florida 32174 —
Hisamitsu Investigator Site Austell Georgia 30106 —
Hisamitsu Investigator Site Savannah Georgia 31405 —
Hisamitsu Investigator Site Stockbridge Georgia 30281 —
Hisamitsu Investigator Site Chicago Illinois 60616 —
Hisamitsu Investigator Site Madisonville Kentucky 42431 —
Hisamitsu Investigator Site Baton Rouge Louisiana 70809 —
Hisamitsu Investigator Site Lake Charles Louisiana 70601 —
Hisamitsu Investigator Site Flint Michigan 48504 —
Hisamitsu Investigator Site Omaha Nebraska 68114 —
Hisamitsu Investigator Site Berlin New Jersey 08009 —
Hisamitsu Investigator Site Raleigh North Carolina 27612 —
Hisamitsu Investigator Site Cincinnati Ohio 45206 —
Hisamitsu Investigator Site Zanesville Ohio 43701 —
Hisamitsu Investigator Site Oklahoma City Oklahoma 73112 —
Hisamitsu Investigator Site Duncansville Pennsylvania 16635 —
Hisamitsu Investigator Site Houston Texas 77074 —
Hisamitsu Investigator Site Salt Lake City Utah 84108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00647231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00647231 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →